Short term clinical efficacy and safety of Tolvaptan additional treatment compared with escalation treatment of conventional diuretics in HF patients with volume overload despite treatments with the conventional diuretics

Trial Profile

Short term clinical efficacy and safety of Tolvaptan additional treatment compared with escalation treatment of conventional diuretics in HF patients with volume overload despite treatments with the conventional diuretics

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 16 May 2016

At a glance

  • Drugs Tolvaptan (Primary) ; Diuretics; Furosemide
  • Indications Heart failure
  • Focus Pharmacodynamics
  • Most Recent Events

    • 24 Apr 2016 Status changed from not yet recruiting to discontinued.
    • 04 Dec 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top